Abstract Cardiovascular disease (CVD) is the leading cause of death worldwide. Risk of CVD is determined by genetic and environmental factors. Numerous dietary factors have been linked to CVD beyond the conventional risk factors. In the past few years, genome-wide association studies have also identified more than 30 genomic loci that determine the susceptibility to cardiovascular events. Genetic background may interact with habitual dietary compositions in predisposition to CVD. In this context, large-scale studies of gene-diet interaction in prospective cohorts or randomized intervention trials have emerged to integrate genetic and dietary risk factors in predicting cardiovascular risk. The use of genetic variants to estimate a causal effect between dietary factors and CVD, namely mendelian randomization analysis, has also been considered in the nutritional epidemiology field. The purpose of this review is to present recent advances in research into dietary and genetic risk factors, gene-diet interactions, and mendelian randomization with regard to CVD risk.
Introduction
Cardiovascular disease (CVD) is the leading cause of death in high-income countries and the second-leading cause of death in medium-and low-income countries [1] . In the past few decades, epidemiology studies have determined a group of risk factors, including lifestyle factors and biochemical markers such as age, obesity, smoking, high levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides, low levels of high-density lipoprotein cholesterol (HDL-C), diabetes mellitus, and hypertension, that may predispose individuals to future CVD. In addition to these established risk factors, recent studies have also associated a variety of dietary or nutrition factors with CVD risk [2] .
Over the past few years, the advent of genome-wide association studies (GWAS) has led to the identification of more than 30 genetic loci underpinnings of CVD [3] . In addition, emerging evidence has indicated that the genetic variations identified from GWAS might interact with dietary factors in determining cardiovascular risk [4••] . Moreover, genetic findings also hold great promise for strengthening causal inference for dietary risk factors with application of the mendelian randomization principle [5••] .
The aim of the present article is to review recent advances regarding the dietary and genetic risk factors for CVD. This review also summarizes recent studies of gene-diet interactions and the use of mendelian randomization in deriving the causality for dietary risk factors.
HDL-C, diabetes mellitus, and hypertension, have been strongly associated with the presence of CVD and explain up to 90% of the events [7, 8] . In addition to these conventional risk factors, a lot of attention has also focused on dietary components. Fat intakes are among the most-studied dietary risk factors in cardiovascular research. Reduction of saturated fat and trans fat intake has been at the heart of most dietary recommendations to reduce the risk of CVD. However, recent findings question the role of saturated fat [9] . Bernstein et al. [10] recently examined the relation between foods that are major dietary protein sources and incident coronary heart disease (CHD). It was found that higher intakes of red meat, red meat excluding processed meat, and high-fat dairy products were significantly associated with elevated risk of CHD. Higher intakes of poultry, fish, and nuts were significantly associated with lower risk. Consumption of sugar-sweetened beverages (SSBs) such as sodas/colas and sweetened fruit drinks have been related to cardiovascular risk factors such as hypertension, adverse lipid parameters, inflammation, weight gain, and diabetes [11] [12] [13] . In the Nurses' Health Study (n088,520), it was found that women who consumed two or more SSBs per day had a 35% greater risk of developing CHD compared with those who consumed less than one SSB per month [14] . The cardiovascular effects were beyond obesity.
A growing body of literature supports the potential effects of many other dietary factors in development of CVD. Mente et al. [15] systematically evaluated the validity of the associations of a group of dietary factors and CHD based on the strength, consistency, temporality, and coherence of the findings. Their data support valid associations of protective factors such as vegetables, nuts, and "Mediterranean" and high-quality dietary patterns, and associations of harmful factors, including intake of trans-fatty acids and foods with a high glycemic index or load [15] . During the past few years, vitamin D has received widespread attention for its potential role in preventing CVD. However, the observational studies of the relation between vitamin D intakes or blood levels and CVD risk generated mixed results. The protective effects of high 25-hydroxyvitamin D levels on incident CVD were reported in some studies, such as the Framingham Offspring Study [16] and the Health Professionals' Follow-Up Study [17] , but not others [18] . Data from a limited number of randomized controlled trials of vitamin D and CVD events showed null relation [18] . Exposure to methylmercury from fish consumption has been equivocally linked to a potentially increased risk of CVD. In a recent study of a total of 51,529 men and 121,700 women, Mozaffarian et al. [19] did not find any clinically relevant adverse effects of mercury exposure on CHD, stroke, or total CVD.
Genetics of Cardiovascular Disease
In epidemiology studies, it has been noted for a long time that family history of CVD is related to increased risk of heart disease [20, 21] . The familial clustering of cardiovascular risk suggests genetic components in predisposing an individual to the disease. Classical genetic epidemiologic analysis in families or twin pairs suggests an underlying multifactorial model of disease susceptibility with a significant polygenic component. The estimated heritability, defined as a proportion of the phenotypic variance accounted for by genetic factors, of CVD or cardiovascular mortality is up to 0.6 [22, 23] . The identification of genes associated with mendelian (or monogenic) CVD provides direct evidence for the genetic roles in the development of CVD [24] . However, until very recent years, little had been known about the specific genomic loci that predispose individuals to CVD. Candidate gene studies and familial linkage studies have been the mainstay of investigation into the genetic component. However, the vast majority of these investigations have not led to the discovery of genes harboring the causal variants for CVD [25, 26••] .
The efforts to discover the CVD genes were recently fueled by GWAS, which examine up to millions of single nucleotide polymorphisms (SNPs) spreading across the human genome. The first wave of GWAS of CVD was published in 2007 [27, 28] . Since then, there has been a sizeable increase in the number of genomic loci associated with CVD outcomes in GWAS. Recent reports from large-scale collaborations such as the Coronary Artery Disease Genome-wide Replication and Meta-analysis (CARDIoGRAM [>140,000 participants]) and the Coronary Artery Disease Genetics consortia (C4D [>70,000 participants]) have expanded the number of susceptibility loci to more than 30 ( Fig. 1 ) [29•, 30, 31] . Among these loci, chromosome 9p21 shows the strongest effect, with an approximately 60% increased risk of myocardial infarction, while other common variants only confer fairly small risk, ranging from 5% to 20%. Most of the GWAS were performed in Caucasians of European descent. In a recent study of a Chinese population, Wang et al. [24] identified a novel locus C6orf105 on chromosome 6p24.1 associated with coronary artery disease. The index SNP rs6903956 was associated with a 51% increased risk, comparable to that of 9p21 in Caucasians. Qi et al. [32] recently tested 14 SNPs identified from GWAS in Caucasians among 1,898 cases with myocardial infarction and 2,096 controls from a Hispanic population. The data indicate both the consistency and disparity of genetic effects on risk of myocardial infarction between Hispanic and white populations. Because different ethnic populations are distinct in genomic structure and may possess population-specific genetic variations [33] , it is promising to detect new genetic variants for CVD by extending the genome-wide search to various populations. In the Nurses' Health Study and the Health Professionals' FollowUp Study, we also noted that the CVD susceptibility in diabetic patients might differ from that of the general population [34, 35•] . This highlights the importance of extending discovery of genetic risk factors specifically affecting the high-risk populations, in which the genetic effects are likely to be modulated by metabolic abnormalities [36] .
Interestingly, it has been noted that most of the CVD loci are not related to any well-established risk factors, though variants at loci such as PCSK9, APOE, and ABO are found to be related to lipid levels [29•] . This may suggest that other novel risk factors or intermediate phenotypes are involved to explain some of the genetic associations. In a recent study, Suhre et al. integrated GWAS and metabolomic profiling that included more than 250 metabolites from 60 biochemical pathways in serum samples from 2,820 individuals. Several of the loci associated with metabolites, such as ABO (with ADpSGEGDFXAEGGGVR/ADSGEGDFXAEGGGVR), NAT2 (with 1-methylxanthine/4-acetamidobutanoate), CPS1 (with glycine), NAT8 (with N-acetylornithine), ALPL (with ADpSGEGDFXAEGGGVR/DSGEGDFXAEGGGVR) and KLKB1 (with bradykinin, des-arg [9] ), were also related to CHD risk. These findings may lead to informative insights into novel mechanisms.
Because the heritability of CVD is substantial, it had been expected that these disease-predisposing genetic markers could also be useful to improve prediction of disease risk beyond conventional risk factors [37] . Ripatti et al. [38] tested SNPs representing 13 genomic regions associated with CHD in 3,829 prevalent CHD cases and 48,897 controls, and a prospective cohort of 30,725 participants (median follow-up, 10.7 years; 1,264 incident CHD cases). However, addition of the genetic markers did not significantly improve the prediction model beyond conventional risk factors. Similarly, we observed significant but modest improvement in discrimination of myocardial infarction status by incorporating GWAS-identified genetic markers into models with conventional clinical risk factors (age, waist-tohip ratio, smoking, alcohol consumption, physical activity, total calories, and family history of CHD) among Hispanics [32] . These data indicate that the currently identified genetic markers may have a modest effect on improvement of disease prediction and may have limited immediate clinical impact.
Gene-Diet Interaction and Cardiovascular Risk
The genetic markers discovered from GWAS only account for a small proportion (<10%) of the disease risk. Various potential mechanisms have been proposed to account for the missing heritability for CVD [39] . Recent data suggest that a part of the missing heritability may be hidden in geneenvironment interaction [40] . In case a gene-environment interaction is present, this interaction may exert a main effect on the likelihood of developing disease, and additional marginal effects result from the independent contributions of genetic and environmental factors. Evidence supports the existence of gene-environment interactions for various conditions such as obesity, diabetes, and CVD [41] [42] [43] . New statistical models have been developed to address detection of gene-environment interaction on a genome-wide scale [44, 45] , though the data from genome-level analysis are still lacking. However, several recent studies carried out in large-scale cohorts or randomized trials provided interesting evidence.
In one study, Do et al. [4••] genotyped four SNPs (rs10757274, rs2383206, rs10757278, rs1333049) at chromosome 9p21, the strongest associated region for CVD [27, 28] , in 8,114 individuals (including 3,820 myocardial infarction cases) with 5 ethnicities-European, South Asian, Chinese, Latin American, and Arab-from the global INTERHEART study and 19,129 individuals (including 1,014 incident cases of CVD) from the prospective FINRISK study [4••] . One of the aims of the study was to test interactions between the genetic variations with dietary patterns in relation to risk of myocardial infarction. Dietary information was measured by a short qualitative food frequency questionnaire (FFQ) of 19 food items in the INTERHEART study and FFQs consisting of up to 130 food items in the FINRISK study. In the INTER-HEART study, three dietary patterns were derived using factor analysis: Oriental (soy sauce, tofu, pickled foods, green leafy vegetables, eggs, and low sugar), Western (eggs, meats, fried and salty foods, sugar, nuts, and desserts), and prudent (raw vegetables, fruits, green leafy vegetables, nuts, desserts, and dairy products). Significant interactions with the prudent diet score were found for all four SNPs, and the strongest interaction was observed for SNP rs2383206 (P00.0004), which remained statistically significant after correcting for multiple testing. Further analysis suggested the interaction was mainly driven by raw vegetable intake, which had the highest factor loadings for the prudent diet score. A closer examination revealed that rs2383206 was strongly associated with myocardial infarction in the group with the lowest prudent diet score (OR, 1.32 [95% CI 1.18-1.48]), while the effect was diminished in a stepwise fashion for the medium-(OR, 1.17 [95% CI, 1.05-1.31]) and high-scoring groups (OR, 1.02 [95% CI, 0.92-1.14]). The interaction was strongest in South Asians and Latin Americans. In the FINRISK study, it was found that SNP rs4977574, a strong proxy SNP for rs2383206, showed significant interaction with consumption of vegetables, fruits, and berries in relation to CVD risk. The hazard ratios for incident CVD among individuals in the low-, medium-, and high-consumption groups were 1.22, 1.35, and 0.96, respectively.
However, most of the findings of gene-diet interactions are not reproducible [41, 43, 46] . The successful detection of gene-diet interactions is dependent on recruiting adequate sample sizes in the prospective settings. In contrast to casecontrol studies, in which dietary intakes are typically collected when disease cases have occurred and may be affected by disease status, prospective cohort studies avoid this inherent bias by gathering dietary and lifestyle information before disease onset. In addition, errors in dietary assessment may limit the study power. This is particularly damaging if the true strengths of the interactive effects are modest. FFQs are the most commonly used tools for assessing long-term intakes in large population studies. However, erroneous self-reporting of these components is a well-known problem. Weighed diet records and multiple 24-hour dietary recalls can provide excellent detail of intake with high accuracy. However, these methods are usually not realistic in large population studies due to heavy respondent burden and poor compliance.
An alternative or better model for testing gene-diet interaction is the randomized intervention trial, in which the intakes of dietary factors are prescribed and potential confounding effects are minimized. Qi et al. [47] recently genotyped IRS1 SNP rs2943641 in 738 overweight adults who were randomly assigned to 1 of 4 diets varying in macronutrient contents for 2 years. It was found that participants with the risk-conferring CC genotype had greater decreases in insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and weight loss than those without this genotype in the highest carbohydrate diet group at 6 months of intervention, whereas an opposite genotype effect on changes in insulin and HOMA-IR was observed in participants assigned to the lowest carbohydrate diet group. At 2 years, the genotype effect on changes in insulin and HOMA-IR remained significant in the highest carbohydrate diet group. This study design may open new avenues in detection of gene-diet interactions. A major challenge remains to find trials with a similar intervention design for replication.
Mendelian Randomization in Causal Inference for Nutrition Risk Factors
A potentially important application of genetic findings in nutrition research is to assist with clarification of the causal link between dietary factors and disease risk [5••] . The vast majority of the relationship between dietary factors and CVD risk has been based on data from observational studies. However, the associations in observational studies are vulnerable to various biases, such as confounding and reverse causality. Mendelian randomization is a recent development that combines genetic and epidemiologic analysis to infer the causality for environmental exposures based on the principle of Mendel's law of independent assortment. In principle, a genetic marker as a proxy for environmental exposure will not suffer from the measurement error and is not correlated with various confounders. Because genotype is allocated at conception, it would not be affected by reverse causality. The study design is akin to a prospective, randomized clinical trial in which individuals are randomly assigned at conception-genotypes of DNA variants are randomly "assigned" to gametes during meiosis. In addition, mendelian randomization analysis takes advantage of the lifelong association between a risk allele and an environmental exposure for CVD to estimate long-term effect. In recent years, genetic studies have provided new insight into genetic determinants of various dietary factors or biochemical markers [34, [48] [49] [50] . Mendelian randomization studies with sufficient statistical power may clarify causality for these potential risk factors. If a risk factor causally affects CVD risk, an association between the risk factor-associated genotypes and CVD risk would be expected, the effect size of which would be commensurate with the genotype-risk factor and risk factor-CVD associations.
Recently, several mendelian randomization analyses were conducted to test the causality for the biochemical risk factors. For example, in one study by the C Reactive Protein (CRP) Coronary Heart Disease Genetics Collaboration [51] , the authors examined four CRP gene-tagging SNPs (rs3093077, rs1205, rs1130864, rs1800947) in 194,418 participants, including 46,557 patients with prevalent or incident CHD. It was found that CRP variants were all associated with up to 30% per allele difference in concentration of CRP (P<10 −34 ) and were unrelated to other risk factors. However, no significant association was seen between the genetic variants and CHD risk. The genetic findings were discordant with the observed risk associated with the corresponding concentration of CRP in prospective studies (P00.001 for difference). This suggests that CRP is unlikely to have a causal role in CHD. In another study, Sarwar et al. [52•] compared CHD risk for genetically (APOA5 rs662799) raised triglyceride concentration (20,842 cases and 35,206 controls) with that recorded for equivalent differences in circulating triglyceride concentration among 302,430 participants (12,785 incident cases during 2.79 million person-years at risk). The OR for CHD was 1.18 (95% CI, 1.11-1.26) per risk allele, which was concordant with the hazard ratio of 1.10 (95% CI, 1.08-1.12) per 16% higher triglyceride concentration recorded in prospective studies. The data support a causal association between triglyceridemediated pathways and CHD.
Large-scale mendelian randomization analysis addressing the causal roles of specific dietary or nutrition factors is currently lacking. However, the recent findings of genomic loci for blood levels of nutrients such as iron metabolites, vitamin D, and vitamin B12 [53] [54] [55] , and dietary intakes such as caffeine [48] may provide a promising opportunity to test the causality for these factors in the near future. The major limitations of mendelian randomization studies of CVD include pleiotropic effects of the genetic variants studied and the lack of adequate statistical power to validate a positive association and (even more tricky) to exclude an association [5••] .
Conclusions and Future Perspectives
In epidemiology studies, a collection of dietary or nutrition factors have been related to CVD risk, in addition to conventional risk factors. Moreover, GWAS have been successful in identifying more than 30 loci associated with CVD. These findings provide insights into the pathophysiology underlying the condition and will have the potential to radically change the practice of cardiovascular medicine. The application of such findings to the prediction of disease risk is premature but holds great promise for causal inference for dietary risk factors using mendelian randomization analysis. Worldwide, striking differences in CVD risk, dietary habits, and genomic structure exist among various populations. The identification of interactions between genetic and dietary factors will be of major scientific and public health importance. Optimally powered, prospective-designed studies with accurate dietary assessment would be imperative in such efforts.
A principal challenge for the next few years will be to delineate the molecular mechanisms underlying dietary factor, genetic variations, and their complex interactions with atherosclerosis. It is noteworthy that recent advances in studying global profiling of epigenetic modifications (epigenome), gene expression (transcriptome), proteins (proteome), and small molecular metabolites (metabolome) may contribute to building links among these various components together [56] [57] [58] . The coupling of research in these new areas with epidemiologic and genetic research would substantially enhance understanding of the currently veiled metabolic pathways. The "dark matter" between genetic predispositions and development of CVD likely will be unraveled in incremental fashion in the years ahead, and there is considerable anticipation of future improvements in disease prevention and treatment based on these projected progresses.
